BAYER, THE MANUFACTURER OF CANCER-CAUSING CHEMICAL GLYPHOSATE ORDERED TO PAY $2.25 BILLION IN DAMAGES, SHARES PLUMIT BY 24%.

In a landmark ruling, Bayer has been ordered to pay $2.25 billion in damages for its cancer-causing weedkiller Roundup, the highest amount yet in its ongoing litigation. This significant verdict follows Bayer’s acquisition of Monsanto in 2018, a move that has since resulted in a 70% decline in Bayer’s market value.

Despite a $9.6 billion settlement in 2020 aimed at resolving most of the pending Roundup cases, Bayer failed to secure court approval for an agreement to prevent future lawsuits, leaving the company vulnerable to further claims.

The financial impact of this latest ruling was immediate, with Bayer’s shares plummeting by 24%. Currently, over 50,000 claims remain pending against Bayer, reflecting the widespread legal challenges the company faces due to Roundup’s link to cancer.

#TheOrganicGuy #OrganicUpdates